Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial

BACKGROUND: A second antipsychotic is commonly added to clozapine to treat refractory schizophrenia, notwithstanding the limited evidence to support such practice. METHODS: The efficacy and adverse effects of this pharmacological strategy were examined in a double-blind, placebo-controlled, 12-week...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Psychopharmacol
Asıl Yazarlar: Barnes, Thomas R.E., Leeson, Verity, Paton, Carol, Marston, Louise, Osborn, David P., Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter M., Husni, Mariwan, Amos, Tim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022882/
https://ncbi.nlm.nih.gov/pubmed/29977519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125318762365
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller